Physician profile
John D Renucci
NPI 1487659827
$17,255.06
in general payments reported to CMS, 2019-2025
7 companies · $9,324 in 2025
The $9,324 reported for 2025 was more than what 94% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $356 · 2020: $89.02 · 2021: $114 · 2022: $195 · 2023: $2,184 · 2024: $4,993 · 2025: $9,324.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $8,925 · Consulting Fee: $3,413 · Travel and Lodging: $2,822 · Food and Beverage: $1,341.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $8,925.00 |
| Consulting Fee | $3,412.50 |
| Travel and Lodging | $2,822.36 |
| Food and Beverage | $1,341.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heron Therapeutics, INC. | $13,405.43 | 2022-2025 | Zynrelef, Aponvie |
| Biotissue Holdings INC. | $2,357.49 | 2023-2025 | |
| Allergan, INC. | $683.59 | 2019-2022 | |
| Abbvie INC. | $604.02 | 2023-2025 | |
| Motiva USA, LLC | $166.54 | 2025 | |
| Stryker Corporation | $21.20 | 2020 | |
| Galderma Laboratories, L.P. | $16.79 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Renucci listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.